Enhancing nicotinamide mononucleotide production in Escherichia coli through systematic metabolic engineering
Journal of Biotechnology · 2025
DOI: 10.1016/j.jbiotec.2025.03.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biotechnology, 2025. Verfasst von Zhaoyuan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, State Key Laboratory of Food Science and Resources, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China; Key La…. Hauptthemen laut MEDLINE: Escherichia coli, Metabolic Engineering, Nicotinamide Mononucleotide. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nicotinamide mononucleotide (NMN) serves as a crucial precursor in the biosynthesis of NAD+ and has garnered significant attention in the food, dietary supplement, and cosmetic industries. This study engineered an Escherichia coli strain for enhancing NMN production. Firstly, the strain with reduced NMN degradation and the ability to transport NMN extracellularly was constructed. Meanwhile, the gene encoding nicotinamide phosphoribosyltransferase (pncA) was disrupted to minimize substrate nicotinamide (NAM) degradation. Then, the induction starting point was optimized to alleviate the metabolic burden on the engineered strain. Subsequently, systematic remodeling of E. coli's glucose metabolism was conducted to enhance its suitability for NMN production by overexpressing key enzymes of the pentose phosphate pathway (Zwf and Gnd), knocking out genes related to the Entner-Doudoroff pathway (gntR and edd), and further attenuating the glycolytic pathway. Then, we concentrated on optimizing the cellular metabolic state, meticulously balancing intracellular redox homeostasis. Finally, using glucose and 2 g/L of NAM as substrates, the extracellular NMN yield reached 4.96 g/L, which is the highest yield reported so far in similar research. These findings contribute to the commercial production of NMN and offer valuable insights for constructing efficient cell factories for other nucleotide compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology, State Key Laboratory of Food Science and Resources, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China; Key Laboratory of Industrial Biotechnology Ministry of Education, and Intern…
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Liu, J., Wang, M., Li, Y., Hou, M., Cao, J., Wu, J., & Su, L. (2025). Enhancing nicotinamide mononucleotide production in Escherichia coli through systematic metabolic engineering. Journal of Biotechnology. https://doi.org/10.1016/j.jbiotec.2025.03.014
Vancouver
Zhang Z, Liu J, Wang M, Li Y, Hou M, Cao J, et al. Enhancing nicotinamide mononucleotide production in Escherichia coli through systematic metabolic engineering. Journal of Biotechnology. 2025. doi:10.1016/j.jbiotec.2025.03.014
BibTeX
@article{Zhang2025,
author = {Zhang, Zhaoyuan and Liu, Jiehu and Wang, Meng and Li, Yang and Hou, Minglei and Cao, Jiaren and Wu, Jing and Su, Lingqia},
title = {Enhancing nicotinamide mononucleotide production in Escherichia coli through systematic metabolic engineering},
journal = {Journal of Biotechnology},
year = {2025},
doi = {10.1016/j.jbiotec.2025.03.014}
}
EUVIMED